Your browser doesn't support javascript.
loading
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Biggi, Alberto; Chauvie, Stephane; Fallanca, Federico; Guerra, Luca; Bergesio, Fabrizio; Menga, Massimo; Bianchi, Andrea; Gregianin, Michele; Chiaravalloti, Agostino; Schillaci, Orazio; Pavoni, Chiara; Patti, Caterina; Picardi, Marco; Romano, Alessandra; Schiavotto, Corrado; Sorasio, Roberto; Viviani, Simonetta; La Nasa, Giorgio; Trentin, Livio; Rambaldi, Alessandro; Gallamini, Andrea.
Affiliation
  • Biggi A; Nuclear Medicine Division, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Chauvie S; Medical Physics Division, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Fallanca F; Nuclear Medicine Division, IRCSS Ospedale San Raffaele, Milano, Italy.
  • Guerra L; Nuclear Medicine Division, Ospedale San Gerardo, Monza, Italy.
  • Bergesio F; Medical Physics Division, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Menga M; Nuclear Medicine Division, Ospedale Trieste, Trieste, Italy.
  • Bianchi A; Nuclear Medicine Division, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Gregianin M; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.
  • Chiaravalloti A; Nuclear Medicine Division, Tor Vergata University, Roma, Italy.
  • Schillaci O; Nuclear Medicine Division, Tor Vergata University, Roma, Italy.
  • Pavoni C; Haematology Division, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Patti C; Haematologiy. Division, V. Cervello Hospital, Palermo, Italy.
  • Picardi M; Clinical Medicine and Surgery Department, Federico II University, Naples, Italy.
  • Romano A; Hematology Division, Policlinico Vittorio Emanuele Hospital, Catania, Italy.
  • Schiavotto C; Hematology Division, S. Bortolo Hospital, Vicenza, Italy.
  • Sorasio R; Haematology Division, Santa Croce e Carle Hospital, Cuneo, Italy.
  • Viviani S; Haematology Division, European Institute of Oncology, Milan, Italy.
  • La Nasa G; Haematology Division, Ospedale R.Binaghi, Cagliari, Italy.
  • Trentin L; Hematology Division, Università di Padova, Padova, Italy.
  • Rambaldi A; Haematology Division, ASST Papa Giovanni XXIII, Bergamo, Italy.
  • Gallamini A; Department Recherche Innovation et Statistique, Centre A. Lacassagne, Nice, France.
Hematol Oncol ; 41(3): 415-423, 2023 Aug.
Article in En | MEDLINE | ID: mdl-36534947
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hematol Oncol Year: 2023 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hodgkin Disease Type of study: Clinical_trials / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Hematol Oncol Year: 2023 Document type: Article Affiliation country: